On April 1 Minister Selby announced the addition of six new cancer drugs to the Manitoba Formulary and the Manitoba Home Cancer Drug Program. Coverage for these drugs will begin on April 16, 2014. [CancerCare Manitoba news item]
“The new drugs include:
- Inlyta and Votrient for the treatment of renal cancer;
- Iressa for the treatment of lung cancer;
- Sutent for the treatment of pancreatic tumours;
- Jakavi for the treatment of myelofibrosis, a bone marrow disorder; and
- Xtandi and Zytiga for the treatment of prostate cancer.”
Here is a selection of papers, websites and a video on breast health for Manitoba teens that might interest you.
Manitoba Health
For Professionals
- Screening Information for Health Care Professionals [CancerCare Manitoba]
- Prostate Cancer Screening: A Review of the Guidelines [CADTH; Nov 2013]
- Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014 Feb 11;348:g366.
For Patients
- Cancer treatment Information – In other languages [CancerCare Manitoba]
Includes patient information in English, French, Chinese, Filipino, Cree, Ojibwe, Oji-Cree, Inuktitut and many others. These are available free in PDF format. - Services for Rural Patients in Manitoba [CancerCare Manitoba]
